BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 33856653)

  • 1. Alteration and dysfunction of ion channels/transporters in a hypoxic microenvironment results in the development and progression of gastric cancer.
    Chen J; Zhang M; Ma Z; Yuan D; Zhu J; Tuo B; Li T; Liu X
    Cell Oncol (Dordr); 2021 Aug; 44(4):739-749. PubMed ID: 33856653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Apoptotic Effect of HIF-1α Inhibition Combined with Glucose plus Insulin Treatment on Gastric Cancer under Hypoxic Conditions.
    Tanaka T; Kitajima Y; Miyake S; Yanagihara K; Hara H; Nishijima-Matsunobu A; Baba K; Shida M; Wakiyama K; Nakamura J; Noshiro H
    PLoS One; 2015; 10(9):e0137257. PubMed ID: 26339797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia decreases macrophage glycolysis and M1 percentage by targeting microRNA-30c and mTOR in human gastric cancer.
    Zhihua Y; Yulin T; Yibo W; Wei D; Yin C; Jiahao X; Runqiu J; Xuezhong X
    Cancer Sci; 2019 Aug; 110(8):2368-2377. PubMed ID: 31222863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired mitophagy activates mtROS/HIF-1α interplay and increases cancer aggressiveness in gastric cancer cells under hypoxia.
    Shida M; Kitajima Y; Nakamura J; Yanagihara K; Baba K; Wakiyama K; Noshiro H
    Int J Oncol; 2016 Apr; 48(4):1379-90. PubMed ID: 26820502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxic gastric cancer-derived exosomes promote progression and metastasis via MiR-301a-3p/PHD3/HIF-1α positive feedback loop.
    Xia X; Wang S; Ni B; Xing S; Cao H; Zhang Z; Yu F; Zhao E; Zhao G
    Oncogene; 2020 Sep; 39(39):6231-6244. PubMed ID: 32826951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia/IL-1α axis promotes gastric cancer progression and drug resistance.
    Xuan Y; Wang YN
    J Dig Dis; 2017 Sep; 18(9):511-520. PubMed ID: 28608600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of different hypoxia models on metastatic potential of SGC-7901 gastric cancer cells.
    Miao ZF; Zhao TT; Wang ZN; Xu YY; Mao XY; Wu JH; Liu XY; Xu H; You Y; Xu HM
    Tumour Biol; 2014 Jul; 35(7):6801-8. PubMed ID: 24729089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-inducible microRNA-224 promotes the cell growth, migration and invasion by directly targeting RASSF8 in gastric cancer.
    He C; Wang L; Zhang J; Xu H
    Mol Cancer; 2017 Feb; 16(1):35. PubMed ID: 28173803
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Zhang J; Guo S; Wu Y; Zheng ZC; Wang Y; Zhao Y
    Biomed Res Int; 2019; 2019():9749751. PubMed ID: 31467922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffuse-type gastric cancer cells switch their driver pathways from FGFR2 signaling to SDF1/CXCR4 axis in hypoxic tumor microenvironments.
    Kinoshita H; Yashiro M; Fukuoka T; Hasegawa T; Morisaki T; Kasashima H; Masuda G; Noda S; Hirakawa K
    Carcinogenesis; 2015 Dec; 36(12):1511-20. PubMed ID: 26385890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockage of Nrf2 suppresses the migration and invasion of esophageal squamous cell carcinoma cells in hypoxic microenvironment.
    Shen H; Yang Y; Xia S; Rao B; Zhang J; Wang J
    Dis Esophagus; 2014; 27(7):685-92. PubMed ID: 24028437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-autophagy axis induces VEGFA by peritoneal mesothelial cells to promote gastric cancer peritoneal metastasis through an integrin α5-fibronectin pathway.
    Wang X; Che X; Yu Y; Cheng Y; Bai M; Yang Z; Guo Q; Xie X; Li D; Guo M; Hou K; Guo W; Qu X; Cao L
    J Exp Clin Cancer Res; 2020 Oct; 39(1):221. PubMed ID: 33081836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRL-3 promotes gastric cancer migration and invasion through a NF-κB-HIF-1α-miR-210 axis.
    Zhang C; Tian W; Meng L; Qu L; Shou C
    J Mol Med (Berl); 2016 Apr; 94(4):401-15. PubMed ID: 26548949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia promotes migration and invasion of gastric cancer cells by activating HIF-1α and inhibiting NDRG2 associated signaling pathway.
    Ou XW; Wang RX; Kang MF; Shi JQ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8237-8247. PubMed ID: 30556863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological significance of hypoxia-inducible factor-1 alpha (HIF-1α) expression in gastric cancer.
    Isobe T; Aoyagi K; Koufuji K; Shirouzu K; Kawahara A; Taira T; Kage M
    Int J Clin Oncol; 2013 Apr; 18(2):293-304. PubMed ID: 22350022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells.
    Mimeault M; Batra SK
    J Cell Mol Med; 2013 Jan; 17(1):30-54. PubMed ID: 23301832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil extracellular traps induced by the hypoxic microenvironment in gastric cancer augment tumour growth.
    Li J; Xia Y; Sun B; Zheng N; Li Y; Pang X; Yang F; Zhao X; Ji Z; Yu H; Chen F; Zhang X; Zhao B; Jin J; Yang S; Cheng Z
    Cell Commun Signal; 2023 May; 21(1):86. PubMed ID: 37127629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia, Inflammation and Necrosis as Determinants of Glioblastoma Cancer Stem Cells Progression.
    Papale M; Buccarelli M; Mollinari C; Russo MA; Pallini R; Ricci-Vitiani L; Tafani M
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32290386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxic Effects on Matrix Metalloproteinases' Expression in the Tumor Microenvironment and Therapeutic Perspectives.
    Gonzalez-Avila G; Sommer B; Flores-Soto E; Aquino-Galvez A
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing circSLAMF6 represses cell glycolysis, migration, and invasion by regulating the miR-204-5p/MYH9 axis in gastric cancer under hypoxia.
    Fang X; Bai Y; Zhang L; Ding S
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32496549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.